Share

January 26, 2016; 86 (4) Article

Overdiagnosis of idiopathic intracranial hypertension

Adeniyi Fisayo, Beau B. Bruce, Nancy J. Newman, Valerie Biousse
First published December 30, 2015, DOI: https://doi.org/10.1212/WNL.0000000000002318
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2667

Share

Article Information

vol. 86 no. 4 341-350
DOI: 
https://doi.org/10.1212/WNL.0000000000002318
PubMed: 
26718577
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 1, 2015
  • Accepted in final form September 16, 2015
  • First Published December 30, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Adeniyi Fisayo, MD,
    2. Beau B. Bruce, MD, PhD,
    3. Nancy J. Newman, MD and
    4. Valerie Biousse, MD
  1. Adeniyi Fisayo, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Beau B. Bruce, MD, PhD,
    3. Scientific Advisory Boards:

    1. MedImmune

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neuro-Ophthalmology Virtual Education Library, Editorial Board, 2014-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis

    Research Support, Government Entities:

    1. NIH/PHS Grant K23-EY019341 2009-present NIH/PHS Grant R01-NS089694 2014-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research to Prevent Blindness

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Bayer, medicolegal consulting, 2014-present United States Government, medicolegal consulting, 2014-2015

  3. Nancy J. Newman, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of Neuro-Ophthalmology, editorial advisory board, > 5 years (2) American Journal of Ophthalmology, executive editor, > 5 years

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Neuro-Ophthalmology Illustrated, Thieme, 2009 (2) Walsh & Hoyt's Clinical Neuro-Ophthalmology The Essentials, 1st and 2nd editions, Lippincott Williams and Wilkins, 1999, 2008 (3) Walsh & Hoyt's Clinical Neuro-Ophthalmology, Lippincott Williams and Wilkins, 5th and 6th editions, 1998, 2005 (4) Blue Books of Neurology: Neuro-Ophthalmology, Butterworth Heinemann Elsevier, 2008

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Trius Pharma -- consultant Gensight -- consultant Santhera -- consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research to Prevent Blindness, New York, N.Y., unrestricted departmental grant, Lew R. Wasserman Merit Award, > 5 years

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. has provided expert testimony on multiple topics in multiple medical legal settings

  4. Valerie Biousse, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial boards of: American Journal of Ophthalmology; Journal of Neuro-ophthalmology

    Patents:

    1. NONE

    Publishing Royalties:

    1. Walsh and Hoyt's Clinical Neuro-Ophthalmology (Lippincott Williams & Wilkins, 2007); Neuro-Ophthalmology Illustrated (Thieme, 2009); Up-to-Date

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. GenSight. Consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research to Prevent Blindness

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Ophthalmology (A.F., B.B.B., N.J.N., V.B.), Neurology (B.B.B., N.J.N., V.B.), and Neurological Surgery (N.J.N.), Emory University School of Medicine; and the Department of Epidemiology (B.B.B.), Rollins School of Public Health and Laney Graduate School, Emory University, Atlanta, GA.
  1. Correspondence to Dr. Biousse: vbiouss{at}emory.edu

Article usage

Article usage: December 2015 to October 2023

AbstractFullPdfSource
Dec 201514006Highwire
Jan 2016322757205Highwire
Feb 20169053188Highwire
Mar 20163732222Highwire
Apr 20162121026Highwire
May 20161941624Highwire
Jun 20161672222Highwire
Jul 20161161424Highwire
Aug 2016153813Highwire
Sep 2016162915Highwire
Oct 20161051026Highwire
Nov 20161001015Highwire
Dec 20168938Highwire
Jan 201784109Highwire
Jan 2017041pmc
Feb 20177742Highwire
Feb 201702513pmc
Mar 20175904Highwire
Mar 201705319pmc
Apr 20176654Highwire
Apr 2017124042pmc
May 20178031Highwire
May 2017144647pmc
Jun 20174701Highwire
Jun 201764341pmc
Jul 20174801Highwire
Jul 2017176872pmc
Aug 20175051Highwire
Aug 2017146978pmc
Sep 20173933Highwire
Sep 2017167478pmc
Oct 20174526Highwire
Oct 2017117672pmc
Nov 20174033Highwire
Nov 201798590pmc
Dec 20175354Highwire
Jan 20186455Highwire
Feb 20183850Highwire
Mar 20186071Highwire
Apr 20184122Highwire
Apr 201811162167pmc
May 20184212Highwire
Jun 20183132Highwire
Jun 20189831914pmc
Jul 20185264Highwire
Aug 20182847Highwire
Aug 20185106109pmc
Sep 20183264Highwire
Oct 20181024042Highwire
Nov 2018662628Highwire
Dec 2018561310Highwire
Jan 20199298Highwire
Feb 2019822912Highwire
Mar 201954128Highwire
Apr 20195767Highwire
May 20195932Highwire
Jun 20194774Highwire
Jul 20195057Highwire
Aug 20199583Highwire
Sep 20198588Highwire
Oct 20197597Highwire
Nov 2019771513Highwire
Dec 201965611Highwire
Jan 202012049Highwire
Feb 20205323Highwire
Mar 20205955Highwire
Apr 20208743Highwire
May 20208033Highwire
Jun 20204674Highwire
Jul 20205126Highwire
Aug 20204003Highwire
Sep 20205558Highwire
Oct 20205755Highwire
Nov 20205165Highwire
Dec 20203765Highwire
Jan 20214115Highwire
Feb 20216016Highwire
Mar 20214227Highwire
Apr 20216326Highwire
May 20214023Highwire
Jun 20214427Highwire
Jul 20214632Highwire
Aug 20213933Highwire
Sep 20216909Highwire
Oct 20215724Highwire
Nov 20214414Highwire
Dec 202113233Highwire
Jan 20226501Highwire
Feb 202211433Highwire
Mar 20226444Highwire
Apr 20228327Highwire
May 20226944Highwire
Jun 20224616Highwire
Jul 20228257Highwire
Aug 20226233Highwire
Sep 20228811Highwire
Oct 2022781210Highwire
Nov 20228055Highwire
Dec 20227474Highwire
Jan 20237210Highwire
Feb 20235684Highwire
Mar 20235344Highwire
Apr 20236900Highwire
May 20236510Highwire
Jun 20233604Highwire
Jul 20235800Highwire
Aug 20235710Highwire
Sep 20234158Highwire
Oct 20234631Highwire

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles